Skip to main content
Veterinary Medicines

Gripork, Injekční emulze

Authorised
  • Swine influenza virus A, H3N2, strain SH, Inactivated
  • Swine influenza virus A, H3N2, strain G, Inactivated
  • Swine influenza virus A, H1N1, strain OLL, Inactivated

Product identification

Medicine name:
Gripork, Injekční emulze
Active substance:
  • Swine influenza virus A, H3N2, strain SH, Inactivated
  • Swine influenza virus A, H3N2, strain G, Inactivated
  • Swine influenza virus A, H1N1, strain OLL, Inactivated
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Swine influenza virus A, H3N2, strain SH, Inactivated
    50.00
    haemagglutination inhibiting unit(s)
    /
    1.00
    Dose
  • Swine influenza virus A, H3N2, strain G, Inactivated
    50.00
    haemagglutination inhibiting unit(s)
    /
    1.00
    Dose
  • Swine influenza virus A, H1N1, strain OLL, Inactivated
    50.00
    haemagglutination inhibiting unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AA03
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • USKVBL
Authorisation number:
  • 97/1274/93-C
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."